A robust system for production of minicircle DNA vectors
Open accessAbstract
Minicircle DNA vectors allow sustained transgene expression in quiescent cells and tissues. To improve minicircle production, we genetically modified Escherichia coli to construct a producer strain that stably expresses a set of inducible minicircle-assembly enzymes, ΦC31 integrase and I-SceI homing endonuclease. This bacterial strain produces purified minicircles in a time frame and quantity similar to those of routine plasmid DNA preparation, making it feasible to use minicircles in place of plasmids in mammalian transgene expression studies.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some researchers use minicircle DNA vectors devoid of prokaryotic and antibiotic DNA sequences for their AAV production.
“Some researchers use, therefore, minicircle DNA vectors devoid of prokaryotic and antibiotic DNA sequences for their AAV production [228].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [228]
The paper’s section on minicircle manufacturing (page unavailable) describes minicircle vectors as lacking the bacterial plasmid backbone. It does not say that researchers use them for AAV production, and the passages do not specifically establish the absence of antibiotic DNA sequences. (LLM, conf=0.86)
Experimental — accuracy not yet measuredDownregulating the Y-box binding protein 1 (YB1) in HEK293T cells did increase the physical titer by 47× for rAAV2, yet it failed to improve the yield for rAAV5.
“Downregulating the Y-box binding protein 1 (YB1) in HEK293T cells did increase the physical titer by 47× for rAAV2, yet it failed to improve the yield for rAAV5 sequences for their AAV production [228].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [228]
The passage under “A Simple And Rapid Minicircle DNA Vector Manufacturing System” (page unavailable) reports yields from bacterial minicircle DNA production, not rAAV production in HEK293T cells. Searches for YB1, HEK293T, the 47-fold rAAV2 titer increase, and rAAV5 yield found no passage addressing the claim. (LLM, conf=0.77)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.
Datsenko, K., & Wanner, B. (2000) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.120163297 · Cited by 15,902 · see citing works
Cherepanov, P., & Wackernagel, W. (1995) · Gene · doi:10.1016/0378-1119(95)00193-a · Cited by 1,952 · see citing works
An efficient recombination system for chromosome engineering in Escherichia coli
Yu, D., Ellis, H. M., Lee, E.-C., Jenkins, N. A., Copeland, N. G., & Court, D. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100127597 · Cited by 1,688 · see citing works
A nonviral minicircle vector for deriving human iPS cells
Jia, F., Wilson, K. D., Sun, N., Gupta, D. M., Huang, M., Li, Z., Panetta, N. J., Chen, Z. Y., Robbins, R. C., Kay, M. A., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1426 · Cited by 734 · see citing works
Self-citationChen, Z.-Y., He, C.-Y., Ehrhardt, A., & Kay, M. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00168-0 · Cited by 463 · see citing works
Self-citationThorpe, H. M., & Smith, M. C. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5505 · Cited by 434 · see citing works
Khlebnikov, A., Keasling, J. D., Wanner, B. L., Skaug, T., & Datsenko, K. A. (2001) · Microbiology · doi:10.1099/00221287-147-12-3241 · Cited by 289 · see citing works
A new DNA vehicle for nonviral gene delivery: supercoiled minicircle
Darquet, A.-M., Cameron, B., Wils, P., Scherman, D., & Crouzet, J. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300540 · Cited by 250 · see citing works
Tan, Y., Li, S., Pitt, B. R., & Huang, L. (1999) · Human Gene Therapy · doi:10.1089/10430349950017149 · Cited by 235 · see citing works
Chen, Z.-Y., He, C.-Y., & Kay, M. A. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.126 · Cited by 180 · see citing works
Self-citationBigger, B., Tolmachov, O. E., Collombet, J.-M., Fragkos, M., Palaszewski, I., & Coutelle, C. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010873200 · Cited by 149 · see citing works
Riu, E., Chen, Z.-Y., Xu, H., He, C.-Y., & Kay, M. A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300177 · Cited by 148 · see citing works
Self-citationMorgan‐Kiss, R. M., Wadler, C. S., & Cronan, J. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122227599 · Cited by 106 · see citing works
Minicircle‐DNA production by site specific recombination and protein–DNA interaction chromatography
Mayrhofer, P., Blaesen, M., Schleef, M., & Jechlinger, W. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1243 · Cited by 102 · see citing works
Novel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction
Huang, M., Chen, Z., Hu, S., Jia, F., Li, Z., Hoyt, G. E., Robbins, R. C., Kay, M. A., & Wu, J. C. (2009) · Circulation · doi:10.1161/circulationaha.108.841155 · Cited by 99 · see citing works
Self-citationPhage TP901-1 Site-Specific Integrase Functions in Human Cells
Stoll, S. M., Ginsburg, D. S., & Calos, M. P. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.13.3657-3663.2002 · Cited by 78 · see citing works
Minaeva, N. I., Gak, E. R., Zimenkov, D. V., Skorokhodova, A., Biryukova, I. V., & Mashko, S. V. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-63 · Cited by 54 · see citing works
Sallam, K. I., Tamura, N., Imoto, N., & Tamura, T. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.02131-09 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123 · see citing works
Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0089-y · Cited by 1,771 · see citing works
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Suzuki, K., Tsunekawa, Y., Hernandez-Benitez, R., Wu, J., Zhu, J., Kim, E. J., Hatanaka, F., Yamamoto, M., Araoka, T., Li, Z., et al. (2016) · Nature · doi:10.1038/nature20565 · Cited by 1,150 · see citing works
State-of-the-art gene-based therapies: the road ahead
Kay, M. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2971 · Cited by 672 · see citing works
Self-citationA Multifunctional AAV-CRISPR-Cas9 and Its Host Response
Chew, W. L., Tabebordbar, M., Cheng, J. K. W., Mali, P., Wu, E. Y., Ng, A. H. M., Zhu, K., Wagers, A. J., & Church, G. M. (2016) · Nature Methods · doi:10.1038/nmeth.3993 · Cited by 617 · see citing works
Zhang, C., Liu, J., Zhong, J. F., & Zhang, X. (2017) · Biomarker Research · doi:10.1186/s40364-017-0102-y · Cited by 578 · see citing works
Niche stiffness underlies the ageing of central nervous system progenitor cells
Segel, M., Neumann, B., Hill, M. F. E., Weber, I. P., Viscomi, C., Zhao, C., Young, A., Agley, C. C., Thompson, A. J., Gonzalez, G. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1484-9 · Cited by 532 · see citing works
Nakade, S., Tsubota, T., Sakane, Y., Kume, S., Sakamoto, N., Obara, M., Daimon, T., Sezutsu, H., Yamamoto, T., Sakuma, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms6560 · Cited by 493 · see citing works
Yarnall, M. T. N., Ioannidi, E. I., Schmitt-Ulms, C., Krajeski, R. N., Lim, J., Villiger, L., Zhou, W., Jiang, K., Garushyants, S. K., Roberts, N., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01527-4 · Cited by 490 · see citing works
Overcoming Nonviral Gene Delivery Barriers: Perspective and Future
Jones, C. H., Chen, C., Ravikrishnan, A., Rane, S., & Pfeifer, B. A. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400467x · Cited by 414 · see citing works
Molecular mechanisms for enhanced DNA vaccine immunogenicity
Li, L., & Petrovsky, N. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1124762 · Cited by 334 · see citing works
Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication
Murphy, C. M., Xu, Y., Li, F., Nio, K., Reszka-Blanco, N., Li, X., Wu, Y., Yu, Y., Xiong, Y., & Su, L. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.026 · Cited by 312 · see citing works
Maresca, M., Lin, V. G., Guo, N., & Yang, Y. (2012) · Genome Research · doi:10.1101/gr.145441.112 · Cited by 310 · see citing works
Chen, Z., Liu, F., Chen, Y., Liu, J., Wang, X., Chen, A. T., Deng, G., Zhang, H., Liu, J., Hong, Z., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703036 · Cited by 297 · see citing works
Self-citationMonjezi, R., Miskey, C., Gogishvili, T., Schleef, M., Schmeer, M., Einsele, H., Ivics, Z., & Hudecek, M. (2016) · Leukemia · doi:10.1038/leu.2016.180 · Cited by 260 · see citing works
Viscous control of cellular respiration by membrane lipid composition
Budin, I., de Rond, T., Chen, Y., Chan, L. J. G., Petzold, C. J., & Keasling, J. D. (2018) · Science · doi:10.1126/science.aat7925 · Cited by 220 · see citing works
Resolving systematic errors in widely used enhancer activity assays in human cells
Muerdter, F., Boryń, Ł. M., Woodfin, A. R., Neumayr, C., Rath, M., Zabidi, M. A., Pagani, M., Haberle, V., Kazmar, T., Catarino, R. R., et al. (2018) · Nature Methods · doi:10.1038/nmeth.4534 · Cited by 208 · see citing works
Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics
Li, H., Saw, P. E., & Song, E. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0417-8 · Cited by 202 · see citing works
CRISPaint allows modular base-specific gene tagging using a ligase-4-dependent mechanism
Schmid-Burgk, J. L., Höning, K., Ebert, T. S., & Hornung, V. (2016) · Nature Communications · doi:10.1038/ncomms12338 · Cited by 190 · see citing works
The future of human DNA vaccines
Li, L., Saadé, F., & Petrovsky, N. (2012) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2012.08.012 · Cited by 180 · see citing works
Engineering DNA vaccines against infectious diseases
Lee, J., Kumar, S. A., Jhan, Y., & Bishop, C. J. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.08.033 · Cited by 176 · see citing works
Vector Design for Improved DNA Vaccine Efficacy, Safety and Production
Williams, J. (2013) · Vaccines · doi:10.3390/vaccines1030225 · Cited by 166 · see citing works
Qin, F., Xia, F., Chen, H., Cui, B., Feng, Y., Zhang, P., Chen, J., & Luo, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.633776 · Cited by 156 · see citing works
Reinson, T., Toots, M., Kadaja, M., Pipitch, R., Allik, M., Ustav, E., & Ustav, M. (2012) · Journal of Virology · doi:10.1128/jvi.01943-12 · Cited by 138 · see citing works
Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction
Sekiba, K., Otsuka, M., Ohno, M., Yamagami, M., Kishikawa, T., Suzuki, T., Ishibashi, R., Seimiya, T., Tanaka, E., & Koike, K. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.010 · Cited by 126 · see citing works
Gracey, L. E., Maniar, J. M., Chen, Z.-Y., Lu, J., Fire, A. Z., & Kay, M. A. (2012) · Molecular Therapy · doi:10.1038/mt.2012.244 · Cited by 121 · see citing works
Self-citationYu, Y., Wu, X., Guan, N., Shao, J., Li, H., Chen, Y., Yuan, P., Li, D., & Ye, H. (2020) · Science Advances · doi:10.1126/sciadv.abb1777 · Cited by 117 · see citing works
New Generation of Plasmid Backbones Devoid of Antibiotic Resistance Marker for Gene Therapy Trials
Vandermeulen, G., Marie, C., Scherman, D., & Véronique Préat, A. (2011) · Molecular Therapy · doi:10.1038/mt.2011.182 · Cited by 113 · see citing works
Systematic evasion of the restriction-modification barrier in bacteria
Johnston, C. D., Cotton, S. L., Rittling, S. R., Starr, J. R., Borisy, G. G., Dewhirst, F. E., & Lemon, K. P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820256116 · Cited by 111 · see citing works
Wei, L., & Ploß, A. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0678-0 · Cited by 110 · see citing works
Baruteau, J., Waddington, S. N., Alexander, I. E., & Gissen, P. (2017) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0053-3 · Cited by 108 · see citing works
Hepatitis B virus cccDNA is formed through distinct repair processes of each strand
Wei, L., & Ploß, A. (2021) · Nature Communications · doi:10.1038/s41467-021-21850-9 · Cited by 105 · see citing works
Han, D. H., Wang, Y., Chen, J., Zhang, J., Yu, P., Zhang, R., Li, S., Bo, T., Wang, Y., Qiu, Y. F., et al. (2019) · Journal of Pineal Research · doi:10.1111/jpi.12571 · Cited by 93 · see citing works
IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis
Adamopoulos, I. E., Suzuki, É., Chao, C., Gorman, D., Adda, S., Maverakis, E. M., Zarbalis, K. S., Geissler, R. H., Asio, A., Blumenschein, W. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204782 · Cited by 93 · see citing works
Buck, T., & Wijnholds, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124197 · Cited by 92 · see citing works
“Some researchers use, therefore, minicircle DNA vectors devoid of prokaryotic and antibiotic DNA sequences for their AAV production [228].”
Gaspar, V. M., Gonçalves, C., de Melo-Diogo, D., Costa, E. C., Queiroz, J. A., Pichon, C., Sousa, F., & Correia, I. J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.040 · Cited by 91 · see citing works
Biomaterials as vectors for the delivery of CRISPR–Cas9
Eoh, J. H., & Gu, L. (2019) · Biomaterials Science · doi:10.1039/c8bm01310a · Cited by 91 · see citing works
Minicircle DNA vectors for gene therapy: advances and applications
Gaspar, V. M., de Melo‐Diogo, D., Costa, E. C., Moreira, A. F., Queiroz, J. A., Pichon, C., Correia, I. J., & de Sousa, F. P. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.996544 · Cited by 91 · see citing works
Expanding the scope of site‐specific recombinases for genetic and metabolic engineering
Gaj, T., Sirk, S. J., & Barbas, C. F. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.25096 · Cited by 88 · see citing works
Antibiotic-free selection in biotherapeutics: Now and forever
Mignon, C., Sodoyer, R., & Werle, B. (2015) · Pathogens · doi:10.3390/pathogens4020157 · Cited by 87 · see citing works
A comprehensive comparison of DNA and RNA vaccines
Wang, C., & Yuan, F. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115340 · Cited by 87 · see citing works
State-of-the-art human gene therapy: part I. Gene delivery technologies.
Wang, D., & Gao, G. (2014) · PubMed · Cited by 85 · see citing works
Utt, A., Quirin, T., Saul, S., Hellström, K., Ahola, T., & Merits, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151616 · Cited by 83 · see citing works
Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy
Nawaz, W., Xu, S., Li, Y., Huang, B., Wu, X., & Wu, Z. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.04.015 · Cited by 81 · see citing works
HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA
Yan, Z., Zeng, J., Yu, Y., Xiang, K., Hu, H., Zhou, X., Gu, L., Wang, L., Zhao, J., Young, J. A. T., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.004 · Cited by 80 · see citing works
Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs
Huang, W., Chen, L., Kang, L., Jin, M., Sun, P., Xin, X., Gao, Z., & Bae, Y. H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.004 · Cited by 77 · see citing works
Elahi, R., Khosh, E., Tahmasebi, S., & Esmaeilzadeh, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01717 · Cited by 77 · see citing works
Tipanee, J., Samara-Kuko, E., Gevaert, T., Chuah, M. K., & VandenDriessche, T. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.06.006 · Cited by 76 · see citing works
Safety and efficacy of DNA vaccines
Stenler, S., Blomberg, P., & Smith, C. E. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28077 · Cited by 74 · see citing works
Treatment of phenylketonuria using minicircle-based naked-DNA gene transfer to murine liver
Viecelli, H. M., Harbottle, R. P., Wong, S. P., Schlegel, A. A., Chuah, M., VandenDriessche, T., Harding, C. O., & Thöny, B. (2014) · Hepatology · doi:10.1002/hep.27104 · Cited by 74 · see citing works
Minicircle DNA Provides Enhanced and Prolonged Transgene Expression Following Airway Gene Transfer
Munye, M. M., Tagalakis, A. D., Barnes, J. L., Brown, R. E., McAnulty, R. J., Howe, S. J., & Hart, S. L. (2016) · Scientific Reports · doi:10.1038/srep23125 · Cited by 72 · see citing works
Converting extracellular vesicles into nanomedicine: loading and unloading of cargo
Joshi, B. S., Ortíz-Rios, D., & Zuhorn, I. S. (2021) · Materials Today Nano · doi:10.1016/j.mtnano.2021.100148 · Cited by 70 · see citing works
Kanada, M., Kim, B. D., Hardy, J. W., Ronald, J. A., Bachmann, M. H., Bernard, M. P., Perez, G. I., Zarea, A. A., Ge, T. J., Withrow, A., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0299 · Cited by 69 · see citing works
Derivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
Narsinh, K., Narsinh, K. H., & Wu, J. C. (2011) · Circulation Research · doi:10.1161/circresaha.111.240374 · Cited by 68 · see citing works
Wan, Q., Xie, L., Gao, L., Wang, Z., Nan, X., Lei, H., Long, X., Chen, Z.-Y., He, C.-Y., Liu, G., et al. (2012) · Nanoscale · doi:10.1039/c2nr32438e · Cited by 64 · see citing works
Self-citationLu, J., Zhang, F., Xu, S., Fire, A. Z., & Kay, M. A. (2012) · Molecular Therapy · doi:10.1038/mt.2012.65 · Cited by 64 · see citing works
Self-citationDNA vaccines for prostate cancer
Zahm, C. D., Colluru, V. T., & McNeel, D. G. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.016 · Cited by 63 · see citing works
Diecke, S., Lu, J., Lee, J., Termglinchan, V., Kooreman, N. G., Burridge, P. W., Ebert, A., Churko, J. M., Sharma, A., Kay, M. A., et al. (2015) · Scientific Reports · doi:10.1038/srep08081 · Cited by 62 · see citing works
Self-citationImproving DNA Vaccine Performance Through Vector Design
Williams, J. (2014) · Current Gene Therapy · doi:10.2174/156652321403140819122538 · Cited by 62 · see citing works
Minicircle DNA is Superior to Plasmid DNA in Eliciting Antigen-specific CD8+ T-cell Responses
Dietz, W., Skinner, N., Hamilton, S. E., Jund, M. D., Heitfeld, S. M., Litterman, A. J., Hwu, P., Chen, Z.-Y., Salazar, A. Μ., Ohlfest, J. R., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.85 · Cited by 62 · see citing works
Self-citationLévi, B., Hyun, J. S., Nelson, E. R., Li, S., Montoro, D. T., Wan, D. C., Jia, F., Glotzbach, J. P., James, A. W., Lee, M., et al. (2011) · Stem Cells · doi:10.1002/stem.757 · Cited by 61 · see citing works
How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?
Sainz-Ramos, M., Gallego, I., Villate-Beitia, I., Sesma, J. Z., Maldonado, I., Puras, G., & Pedraz, J. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147545 · Cited by 59 · see citing works
Walters, A. A., Kinnear, E., Shattock, R. J., McDonald, J. U., Caproni, L. J., Porter, N., & Tregoning, J. S. (2014) · Gene Therapy · doi:10.1038/gt.2014.37 · Cited by 58 · see citing works
Vectorology and Factor Delivery in Induced Pluripotent Stem Cell Reprogramming
Hu, K. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0621 · Cited by 58 · see citing works
Sekiba, K., Otsuka, M., Ohno, M., Yamagami, M., Kishikawa, T., Seimiya, T., Suzuki, T., Tanaka, E., Ishibashi, R., Funato, K., et al. (2018) · Hepatology · doi:10.1002/hep.30491 · Cited by 55 · see citing works
A Mini-intronic Plasmid (MIP): A Novel Robust Transgene Expression Vector In Vivo and In Vitro
Lu, J., Zhang, F., & Kay, M. A. (2013) · Molecular Therapy · doi:10.1038/mt.2013.33 · Cited by 54 · see citing works
Self-citationSankovski, E., Männik, A., Geimanen, J., Ustav, E., & Ustav, M. (2013) · Journal of Virology · doi:10.1128/jvi.01841-13 · Cited by 53 · see citing works
Detecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarker
Ronald, J. A., Chuang, H., Dragulescu‐Andrasi, A., Hori, S. S., & Gambhir, S. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414156112 · Cited by 52 · see citing works
Mapping the Interactions of HBV cccDNA with Host Factors
Mohd-Ismail, N. K., Lim, Z., Gunaratne, J., & Tan, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174276 · Cited by 51 · see citing works
Non-viral therapeutic approaches to ocular diseases: An overview and future directions
Zulliger, R., Conley, S. M., & Naash, M. I. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.007 · Cited by 50 · see citing works
Managing MicroRNAs with Vector-Encoded Decoy-Type Inhibitors
Bak, R. O., Hollensen, A. K., & Mikkelsen, J. G. (2013) · Molecular Therapy · doi:10.1038/mt.2013.113 · Cited by 49 · see citing works
Vaccine development for bacterial pathogens: Advances, challenges and prospects
Mba, I. E., Sharndama, H. C., Anyaegbunam, Z. K. G., Anekpo, C. C., Amadi, B. C., Daji, M., Doowuese, Y., Ihezuo, U. J., Chukwukelu, J. U., & Okeke, O. P. (2023) · Tropical Medicine & International Health · doi:10.1111/tmi.13865 · Cited by 47 · see citing works
Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing
Gonçalves, G. A. L., Bower, D. M., Prazeres, D. M. F., Monteiro, G. A., & Prather, K. L. J. (2011) · Biotechnology Journal · doi:10.1002/biot.201100062 · Cited by 47 · see citing works
The Cell Cycle Timing of Human Papillomavirus DNA Replication
Reinson, T., Henno, L., Toots, M., Ustav, M., & Ustav, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131675 · Cited by 47 · see citing works
Abere, B., Zhou, H., Li, J., Cao, S., Toptan, T., Grundhoff, A. T., Fischer, N., Moore, P. S., & Chang, Y. (2020) · mBio · doi:10.1128/mbio.03059-20 · Cited by 46 · see citing works
Wang, Q., Jiang, W., Chen, Y., Liu, P., Sheng, C., Chen, S., Zhang, H., Pan, C., Gao, S., & Huang, W. (2013) · Journal of Virology · doi:10.1128/jvi.02757-13 · Cited by 45 · see citing works
Cell Culture Models and Animal Models for HBV Study
Li, F., Wang, Z., Hu, F., & Su, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9151-4_5 · Cited by 45 · see citing works
Guo, X., Chen, P., Hou, X., Xu, W., Wang, D., Wang, T.-Y., Zhang, L., Zheng, G., Gao, Z., He, C., et al. (2016) · Scientific Reports · doi:10.1038/srep25552 · Cited by 44 · see citing works
Self-citationBartholomeeusen, K., Utt, A., Coppens, S., Rausalu, K., Vereecken, K., Ariën, K. K., & Merits, A. (2018) · Journal of Virology · doi:10.1128/jvi.00152-18 · Cited by 44 · see citing works
Jakobsen, J. E., Johansen, M., Schmidt, M. H., Dagnæs‐Hansen, F., Dam, K., Gunnarsson, A., Liu, Y., Kragh, P. M., Li, R., Holm, I. E., et al. (2012) · Transgenic Research · doi:10.1007/s11248-012-9671-6 · Cited by 44 · see citing works
Mammalian synthetic biology for studying the cell
Mathur, M., Xiang, J. S., & Smolke, C. D. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201611002 · Cited by 43 · see citing works
Calcium phosphate nanoneedle based gene delivery system for cancer genetic immunotherapy
Zhao, J., Chen, G., Pang, X., Zhang, P., Hou, X., Chen, P., Xie, Y.-W., He, C., Wang, Z., & Chen, Z. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120072 · Cited by 43 · see citing works
Self-citationEtanercept-Synthesising Mesenchymal Stem Cells Efficiently Ameliorate Collagen-Induced Arthritis
Park, N., Rim, Y. A., Jung, H., Kim, J., Yi, H., Kim, Y., Jang, Y., Jung, S. M., Lee, J. J., Kwok, S., et al. (2017) · Scientific Reports · doi:10.1038/srep39593 · Cited by 42 · see citing works
The march of pluripotent stem cells in cardiovascular regenerative medicine
Abou-Saleh, H., Zouein, F. A., El-Yazbi, A., Sanoudou, D., Raynaud, C., Rao, C., Pintus, G., Dehaini, H., & Eid, A. (2018) · Stem cell research & therapeutics · doi:10.1186/s13287-018-0947-5 · Cited by 39 · see citing works
Gao, L., Xie, L., Long, X., Wang, Z., He, C.-Y., Chen, Z.-Y., Zhang, L., Nan, X., Lei, H., Liu, X., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.094 · Cited by 40 · see citing works
Self-citationMun, J.-Y., Shin, K. K., Kwon, O., Lim, Y. T., & Oh, D. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.057 · Cited by 40 · see citing works
Delivery of a sebum modulator by an engineered skin microbe in mice
Knödlseder, N., Fábrega, M.-J., Santos‐Moreno, J., Manils, J., Toloza, L., Vilar, M. M., Fernández, C., Broadbent, K., Maruotti, J., Leménager, H., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-02072-4 · Cited by 39 · see citing works
Kim, Y., Yi, H., Jung, H., Rim, Y. A., Park, N., Kim, J., Jung, S. M., Park, S., Park, Y. W., & Ju, J. H. (2016) · Scientific Reports · doi:10.1038/srep20150 · Cited by 39 · see citing works
An update on ACE2 amplification and its therapeutic potential
Márquez, A., Wysocki, J. A., Pandit, J. A., & BATLLE, D. C. (2020) · Acta Physiologica · doi:10.1111/apha.13513 · Cited by 39 · see citing works
Bacteriophage recombination systems and biotechnical applications
Nafissi, N., & Slavcev, R. A. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5512-2 · Cited by 38 · see citing works
Grant, R., Hay, D. C., & Callanan, A. (2018) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/aacbe1 · Cited by 36 · see citing works
Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors
Williams, J. A., & Paez, P. A. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.04.003 · Cited by 35 · see citing works
DNA-Based Nonviral Gene Therapy─Challenging but Promising
Guan, X., Pei, Y., & Song, J. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00907 · Cited by 35 · see citing works
Macrophage-specific in vivo RNA editing promotes phagocytosis and antitumor immunity in mice
Chen, Y., Chen, X., Zhang, Y., Wang, M., Yang, M., Wang, R. Y., Yan, X., Shao, S., Xin, H., Hu, Q., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adl5800 · Cited by 35 · see citing works
Efficient Sleeping Beauty DNA Transposition From DNA Minicircles
Sharma, N., Cai, Y., Bak, R. O., Jakobsen, M. R., Schrøder, L. D., & Mikkelsen, J. G. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.1 · Cited by 34 · see citing works
Stenler, S., Wiklander, O. P. B., Tejedor, M. B., Turunen, J. J., Nordin, J. Z., Hallengärd, D., Wahrén, B., Andaloussi, S. E., Rutland, M. W., Smith, C. E., et al. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.67 · Cited by 34 · see citing works
DNA Ministrings: Highly Safe and Effective Gene Delivery Vectors
Nafissi, N., Alqawlaq, S., Lee, E. A., Földvári, M., Spagnuolo, P. A., & Slavcev, R. A. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.16 · Cited by 34 · see citing works
Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
Gaspar, V. M., Maia, C. J., Queiroz, J. A., Pichon, C., Correia, I. J., & de Sousa, F. P. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.020 · Cited by 34 · see citing works
Towards effective non-viral gene delivery vector
Šimčíková, M., Prather, K. L. J., Prazeres, D. M. F., & Monteiro, G. A. (2015) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2016.1178011 · Cited by 33 · see citing works
Florian, M., Wang, J.-P., Deng, Y., Souza‐Moreira, L., Stewart, D. J., & Mei, S. H. J. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02245-5 · Cited by 33 · see citing works
- Authors
- Kay, M. A., He, C.-Y., & Chen, Z.-Y.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Kay, Mark A
- ORCID
- Kay, Mark A
- Venue
- Nature Biotechnology
- Published
- 2010-11-21
- Volume
- 28
- Issue
- 12
- Pages
- 1287-1289
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4144359
- OpenAlex
- W2079903460
- Cited by
- 329
- References
- 18
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 21 · 2023: 20 · 2022: 17 · 2021: 28 · 2020: 20 · 2019: 22 · 2018: 19 · 2017: 17 · 2016: 28 · 2015: 24 · 2014: 31 · 2013: 23 · 2012: 16
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL064274, R01HL064274)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- transgene expression, gene transfer
- MeSH terms
- Biotechnology, Cloning, Molecular, DNA, Circular, Escherichia coli, Genetic Vectors, Plasmids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review